Navigation Links
XTENT Announces First Quarter 2008 Financial Results
Date:4/28/2008

ext month in Barcelona, Spain."

CUSTOM III Long and Multi-lesion Trial Six-Month Data To Be Presented At EuroPCR

Six-month follow-up data from the CUSTOM III clinical trial will be presented at the annual EuroPCR meeting, taking place May 13 through 16 in Barcelona, Spain. The company will exhibit as well as host a symposium on customizable drug-eluting stents.

Schedule of XTENT Events for EuroPCR

Tuesday, May 13, 2008, 3:30-6:30 p.m. CEST

Late-Breaking Clinical Trial: CUSTOM III trial 6-month follow-up results. Bernard de Bruyne, M.D., Ph.D., Cardiovascular Center, OLV Hospital in Aalst, Belgium, the principal investigator of the CUSTOM III clinical trial, will present six-month follow-up data from the CUSTOM III trial evaluating use of the Custom NX(R) Drug Eluting Stent (DES) System in patients with long or multiple coronary lesions.

Wednesday, May 14, 2008, 5:00-6:30 p.m. CEST

Evening symposium: Customizable drug-eluting stents: a breakthrough approach to the percutaneous treatment of coronary artery disease.

The symposium will provide an overview of the Custom NX DES System with respect to the treatment of long and multi-lesion coronary artery disease, and the CUSTOM clinical program.

About the Custom NX(R) DES System

Custom NX is designed to enable a more personalized approach to the treatment of arterial disease based on each patient's individual lesion characteristics. The Custom NX system allows physicians to customize the length and diameter of the stent at the site of the lesion. The system features a proprietary modular stent design that consists of multiple 6mm cobalt chromium segments coated with Biolimus A9(R) and PLA, a biodegradable drug carrier. The Custom NX delivery system enables separation at each 6mm segment and allows for the placement of up to 60mm of stent.

About XTENT

XTENT, Inc. is a medical device company focused on developing and commercializing
'/>"/>

SOURCE XTENT, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. XTENT to Present CUSTOM I and CUSTOM II Trial Data at TCT 2007
2. XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System
3. Study Data Show Asacol(R) (Mesalamine) is Effective in Treating All Extents of Ulcerative Colitis Including Isolated Proctitis
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... -- STEPh, Inc., a full service medical communications company, ... site ( http://www.stephreports.com ) dedicated to investigational ... Reports STEPh Reports are comprehensive critical reviews ... Report assesses the competitive landscape by individual drug monograph, ... specific key issues.  STEPh Reports are written by individuals ...
(Date:5/22/2013)... Minn. , May 22, 2013 /PRNewswire/ ... the successful completion of its global Phase ... an internally developed program for the management ... proprietary formulation technology.  USL255 is specifically engineered ... fluctuations in topiramate blood levels observed with ...
(Date:5/22/2013)... 2013 MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) would ... some recent company developments. As Medifirst continues to expand ... with shareholders. Integrating social media into its investor relations ... will post updates on Twitter.  The Facebook homepage is ... Says CEO Bruce J. Schoengood ...
Breaking Medicine Technology:Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 3Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 4Medifirst Solutions, Inc. Announces Update To Shareholders 2
(Date:5/23/2013)... 2013 Long-Term Care Insurance shopping ... rate at which applicants for Long Term Care Insurance are ... , The decision to buy a Long Term Care ... willing and able to purchase protection are increasingly being turned ... any price. A variety of chronic conditions appear to ...
(Date:5/23/2013)... AttorneyOne.com, a recognized authority on law, ... providing expert opinion in view of the recent news ... to court documents, on March 5, 2013 a woman ... no. 3:2013cv50102) alleging that her husband suffered massive brain ... is mainly used as a blood thinner for patients ...
(Date:5/22/2013)... St. Petersburg, FL (PRWEB) May 23, 2013 ... rarely affects men due to several factors, including estrogen ... Cellulite is essentially toxins and fatty deposits stored and ... skin. "To diminish cellulite, one must take a multi-pronged ... These multi-pronged actions include: , Specific products like ...
(Date:5/22/2013)... research shows that bicyclists who wear helmets have an ... at Boston Children,s Hospital found that simply having bicycle ... in deaths and injuries for children younger than 16 ... The cross-sectional study, conducted by William P. Meehan III, ... MD, MPH of Boston Children,s Hospital, and Christopher M. ...
(Date:5/22/2013)... Dr. Andrew Satlin offers patients with ... the Laser Assisted New Attachment Procedure (LANAP). May is Stroke ... connections between gum disease and stroke. Periodontal disease is one ... today, and is linked to an increased risk for strokes ... infected gum pockets. , Periodontal disease is essentially an ...
Breaking Medicine News(10 mins):Health News:More Baby Boomers Rejected by Long Term Care Insurance Companies 2Health News:More Baby Boomers Rejected by Long Term Care Insurance Companies 3Health News:New Lawsuit on Pradaxa Brain Hemorrhage: Now, AttorneyOne Can Provide Advice 2Health News:Get Cellulite Under Control Now with Cellulite Whisperer® Products Introduced by Sublime Beauty® 2Health News:Rate of bicycle-related fatalities significantly lower in states with helmet laws 2Health News:For Stroke Awareness Month, Dr. Andrew Satlin is Raising Awareness of the Connections Between Gum Disease and Stroke and Offers Encino, CA Laser Gum Surgery for Treatment 2
... 2008VANCOUVER, April 20 /PRNewswire-FirstCall/ - Response Biomedical Corporation ... revenues for the three-month period ended March 31, ... $2.526 million compared to $1.173 million for the ... revenues for any quarter in the Company,s history ...
... Intervention Will Retain Decision Resources, Clinical Gold Standard ... from Decision ResourcesWALTHAM, Mass., April 20 Decision ... advisory firms for pharmaceutical and healthcare issues, finds ... mortality as the attribute that most influences their ...
... Friends , BURLINGTON, Mass. , April 20 ... known for allergy-friendly desserts and snacks, is pleased to ... character whose TV show entertains kids while providing insight ... of growing up. Launched in 2004, Cherrybrook Kitchen has ...
... N.J., April 20 UNICO National, the largest Italian ... to announce its 2009 Award recipients. The Awardees will ... in Lake Las Vegas, NV this July. Americanism ... Award Alan Krutchkoff, Fairlawn, NJFounder of the ...
... to The Leukemia & Lymphoma SocietyWHITE PLAINS, N.Y., April 20 ... that mothers perform on behalf of their children and other ... do something special to pay tribute to mothers.Consider the heroic ... is nothing more terrifying for a mother than to watch ...
... love Scent To Sleep products so much, we bought ... (ICP) announced today that ICP has acquired Scent To ... and distributes a revolutionary All Natural Non-Drowsy Sleep Mist ... love Scent To Sleep products so much, we bought ...
Cached Medicine News:Health News:Response Biomedical Corporation Delivers Record Preliminary Revenues in First Quarter 2Health News:Response Biomedical Corporation Delivers Record Preliminary Revenues in First Quarter 3Health News:Response Biomedical Corporation Delivers Record Preliminary Revenues in First Quarter 4Health News:For Reducing Mortality, Current and Emerging Therapies Have No Advantage Over Carvedilol in the Treatment of Coronary Heart Disease (Stable Angina) 2Health News:For Reducing Mortality, Current and Emerging Therapies Have No Advantage Over Carvedilol in the Treatment of Coronary Heart Disease (Stable Angina) 3Health News:Cherrybrook Kitchen Announces New Partnership With Arthur 2Health News:Cherrybrook Kitchen Announces New Partnership With Arthur 3Health News:UNICO National Announces 2009 Award Winners 2Health News:UNICO National Announces 2009 Award Winners 3Health News:This Mother's Day Celebrate a Mother's Love 2Health News:Scent To Sleep All Natural Non-Drowsy Sleep Mist Acquired by Innovative Custom Products, Inc. (ICP) 2
... GORE-TEX Stretch Vascular Grafts have met ... vascular procedures. Recognized for exceptional performance ... endorsement of renowned surgeons worldwide. These ... and the spread of infection, and ...
... GORE-TEX INTERING Vascular Graft, the newest vascular ... Associates, a leader in vascular surgical products ... performance by reducing kinking and compression ... This new graft provides all of the ...
... GORE-TEX INTERING Vascular Graft, the newest vascular ... Associates, a leader in vascular surgical products ... performance by reducing kinking and compression ... This new graft provides all of the ...
... EpochXP Workstations provide comprehensive neurological monitoring ... care unit to accurately access your ... over 15 years experience, and a ... EpochXP neurological monitoring systems have a ...
Medicine Products: